Recruiting studies: Methamphetamine Dependence

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Glutide for Ending Methamphetamine
Phase 2 · 1 location(s) · San Francisco Department of Public Health · NCT07204249 Psilocybin for Methamphetamine Addiction
EARLY_Phase 1 · 1 location(s) · Kevin Murnane · NCT06899594 Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NA · 2 location(s) · Wake Forest University Health Sciences · NCT04927143 Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder
Phase 2 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT06788587 Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users
Phase 2 · 4 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05854667 Smartphone Services for Stimulant Use Disorder
NA · 1 location(s) · DynamiCare Health · NCT07092059 Role of Pavlovian Mechanisms for Control Over Substance Use
Phase N/A · 1 location(s) · Technische Universität Dresden · NCT06701487 Creatine for Depressed Male and Female Methamphetamine Users
Phase 3 · 1 location(s) · Montana State University · NCT02568878

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.